Skip to main content
Journal cover image

Racial differences in long-term outcomes among black and white patients with drug-eluting stents.

Publication ,  Journal Article
Sullivan, LT; Mulder, H; Chiswell, K; Shaw, LK; Wang, TY; Jackson, LR; Thomas, KL
Published in: Am Heart J
August 2019

BACKGROUND: Some studies suggest that black patients may have worse outcomes after drug-eluting stent (DES) placement. There are limited data characterizing long-term outcomes by race. The objective was to compare long-term outcomes between black and white patients after percutaneous coronary intervention (PCI) with DES implantation. METHODS: We analyzed 915 black and 3,559 white (n = 4,474) consecutive patients who underwent DES placement at Duke University Medical Center from 2005 through 2013. Over 6-year follow up, we compared rates of myocardial infarction (MI), all-cause mortality, revascularization, and major bleeding between black and white patients. A multivariable Cox regression model was fit to adjust for potentially confounding variables. Dual-antiplatelet therapy use over time was determined by patient follow-up surveys and compared by race. RESULTS: Black patients were younger; were more often female; had higher body mass indexes; had more diabetes mellitus, hypertension, and renal disease; and had lower median household incomes than white patients (P < .001). At 6 years after DES placement, black relative to white patients had higher unadjusted rates of MI (12.1% vs 10.1%, hazard ratio 1.25, 95% CI 1.00-1.57, P = .05) and major bleeding (17.8% vs 14.3%, hazard ratio 1.28, 95% CI 1.07-1.54, P = .01), but there were no significant differences in other outcomes. After multivariable adjustment, there were no statistically significant racial differences in any of these outcomes at 6 years. Similarly, dual-antiplatelet therapy use was comparable between racial groups. CONCLUSIONS: Unadjusted rates of MI and major bleeding over long-term follow up were higher among black patients compared to white patients, but these differences may be explained by racial differences in comorbid disease.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

August 2019

Volume

214

Start / End Page

46 / 53

Location

United States

Related Subject Headings

  • White People
  • Treatment Outcome
  • ST Elevation Myocardial Infarction
  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Myocardial Revascularization
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Kidney Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sullivan, L. T., Mulder, H., Chiswell, K., Shaw, L. K., Wang, T. Y., Jackson, L. R., & Thomas, K. L. (2019). Racial differences in long-term outcomes among black and white patients with drug-eluting stents. Am Heart J, 214, 46–53. https://doi.org/10.1016/j.ahj.2019.04.005
Sullivan, Lonnie T., Hillary Mulder, Karen Chiswell, Linda K. Shaw, Tracy Y. Wang, Larry R. Jackson, and Kevin L. Thomas. “Racial differences in long-term outcomes among black and white patients with drug-eluting stents.Am Heart J 214 (August 2019): 46–53. https://doi.org/10.1016/j.ahj.2019.04.005.
Sullivan LT, Mulder H, Chiswell K, Shaw LK, Wang TY, Jackson LR, et al. Racial differences in long-term outcomes among black and white patients with drug-eluting stents. Am Heart J. 2019 Aug;214:46–53.
Sullivan, Lonnie T., et al. “Racial differences in long-term outcomes among black and white patients with drug-eluting stents.Am Heart J, vol. 214, Aug. 2019, pp. 46–53. Pubmed, doi:10.1016/j.ahj.2019.04.005.
Sullivan LT, Mulder H, Chiswell K, Shaw LK, Wang TY, Jackson LR, Thomas KL. Racial differences in long-term outcomes among black and white patients with drug-eluting stents. Am Heart J. 2019 Aug;214:46–53.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

August 2019

Volume

214

Start / End Page

46 / 53

Location

United States

Related Subject Headings

  • White People
  • Treatment Outcome
  • ST Elevation Myocardial Infarction
  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Myocardial Revascularization
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Kidney Diseases